These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 30125322)

  • 1. Prior administration of vitamin K2 improves the therapeutic effects of zoledronic acid in ovariectomized rats by antagonizing zoledronic acid-induced inhibition of osteoblasts proliferation and mineralization.
    Zhao B; Zhao W; Wang Y; Zhao Z; Zhao C; Wang S; Gao C
    PLoS One; 2018; 13(8):e0202269. PubMed ID: 30125322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined teriparatide and zoledronic acid on posterior lumbar vertebral fusion in an aged ovariectomized rat model of osteopenia.
    Yishake M; Yasen M; Jiang L; Liu W; Xing R; Chen Q; Lin H; Dong J
    J Orthop Res; 2018 Mar; 36(3):937-944. PubMed ID: 28796280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of zoledronic acid on spinal fusion outcomes in an ovariectomized rat model of osteoporosis.
    Yasen M; Li X; Jiang L; Yuan W; Che W; Dong J
    J Orthop Res; 2015 Sep; 33(9):1297-304. PubMed ID: 26011820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K2 stimulates MC3T3‑E1 osteoblast differentiation and mineralization through autophagy induction.
    Li W; Zhang S; Liu J; Liu Y; Liang Q
    Mol Med Rep; 2019 May; 19(5):3676-3684. PubMed ID: 30896842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
    Li GW; Xu Z; Chang SX; Zhou L; Wang XY; Nian H; Shi X
    Endocrinology; 2014 Dec; 155(12):4731-8. PubMed ID: 25243855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
    Pozzi S; Vallet S; Mukherjee S; Cirstea D; Vaghela N; Santo L; Rosen E; Ikeda H; Okawa Y; Kiziltepe T; Schoonmaker J; Xie W; Hideshima T; Weller E; Bouxsein ML; Munshi NC; Anderson KC; Raje N
    Clin Cancer Res; 2009 Sep; 15(18):5829-39. PubMed ID: 19737962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid modulates osteoclast apoptosis through activation of the NF-κB signaling pathway in ovariectomized rats.
    Cheng YT; Liao J; Zhou Q; Huo H; Zellmer L; Tang ZL; Ma H; Hong W; Liao DJ
    Exp Biol Med (Maywood); 2021 Aug; 246(15):1727-1739. PubMed ID: 33926259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action.
    Niu YB; Li YH; Kong XH; Zhang R; Sun Y; Li Q; Li C; Liu L; Wang J; Mei QB
    Osteoporos Int; 2012 Nov; 23(11):2649-60. PubMed ID: 22535190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface.
    Li YF; Li XD; Bao CY; Chen QM; Zhang H; Hu J
    Osteoporos Int; 2013 Mar; 24(3):1063-71. PubMed ID: 23296744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of ovariectomy-induced osteoporosis in rats : Comparative study of zoledronic acid, parathyroid hormone (1-34) and strontium ranelate.
    Tao ZS; Zhou WS; Wu XJ; Zhang X; Wang L; Xie JB; Xu ZJ; Ding GZ; Yang M
    Z Gerontol Geriatr; 2019 Mar; 52(2):139-147. PubMed ID: 29476205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
    Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model.
    Little DG; McDonald M; Bransford R; Godfrey CB; Amanat N
    J Bone Miner Res; 2005 Nov; 20(11):2044-52. PubMed ID: 16234978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model.
    Korn P; Kramer I; Schlottig F; Tödtman N; Eckelt U; Bürki A; Ferguson SJ; Kautz A; Schnabelrauch M; Range U; Kneissel M; Stadlinger B
    Eur Cell Mater; 2019 May; 37():333-346. PubMed ID: 31112281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanohydroxyapatite Based Ceramic Carrier Promotes Bone Formation in a Femoral Neck Canal Defect in Osteoporotic Rats.
    Qayoom I; Teotia AK; Kumar A
    Biomacromolecules; 2020 Feb; 21(2):328-337. PubMed ID: 31637919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
    Zara S; De Colli M; di Giacomo V; Zizzari VL; Di Nisio C; Di Tore U; Salini V; Gallorini M; Tetè S; Cataldi A
    Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
    Schindeler A; Little DG
    Biochem Biophys Res Commun; 2005 Dec; 338(2):710-6. PubMed ID: 16243296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.
    Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
    Clin Oral Investig; 2016 Nov; 20(8):2023-2035. PubMed ID: 26795621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.